Manufacture

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.

A team at the University of Bath have found a more efficient way to produce drugs using a catalyst powered by 420 nanometer blue light.

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.

A whistle-stop tour of the mechanisms, benefits, manufacturing challenges, and clinical potential of CAR T cells, TCR T cells, TILs, and NK cells.

Joe Sinclair gives his view on how to be successful with oncolytic virotherapy.

Watch our video interview with We interview Joe Healey, CEO and Co-Founder of NanoSyrinx.

We interview Sharon Brownlow from the Cell & Gene Therapy Catapult about her career and the top trends in cell therapy.

We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.

The latest issue of The Bioprocess Curator included a lot of interesting news about vaccines. In case you missed it, here's some of the top stories.

Edd Stone of The Technology Partnership outlines current challenges in the cell and gene field - and what we can do about them.